| A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer A Kulkarni, V Chandrasekar, SK Natarajan, A Ramesh, P Pandey, ... Nature biomedical engineering 2 (8), 589, 2018 | 174 | 2018 |
| A microfluidic platform for drug screening in a 3D cancer microenvironment HJ Pandya, K Dhingra, D Prabhakar, V Chandrasekar, SK Natarajan, ... Biosensors and Bioelectronics 94, 632-642, 2017 | 82 | 2017 |
| Reporter nanoparticle that monitors its anticancer efficacy in real time A Kulkarni, P Rao, S Natarajan, A Goldman, VS Sabbisetti, Y Khater, ... Proceedings of the National Academy of Sciences 113 (15), E2104-E2113, 2016 | 79 | 2016 |
| Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance A Goldman, S Khiste, E Freinkman, A Dhawan, B Majumder, J Mondal, ... Science signaling 12 (595), eaas8779, 2019 | 61 | 2019 |
| Combining immune checkpoint inhibitors and kinase-inhibiting supramolecular therapeutics for enhanced anticancer efficacy A Kulkarni, SK Natarajan, V Chandrasekar, PR Pandey, S Sengupta ACS nano 10 (10), 9227-9242, 2016 | 46 | 2016 |
| Algorithm for designing nanoscale supramolecular therapeutics with increased anticancer efficacy A Kulkarni, P Pandey, P Rao, A Mahmoud, A Goldman, V Sabbisetti, ... ACS nano 10 (9), 8154-8168, 2016 | 22 | 2016 |
| AT1965, a novel B cell-activating immunotherapy, exerts potent anticancer activity M Roy, V Krishna, A Sengupta, S Roy, A Kulkarni, S Sengupta Cancer Research 78 (13 Supplement), 4712-4712, 2018 | | 2018 |
| Towards understanding the cellular uptake patterns of nano-particles among different immune cell lines N Ismail, A Kulkarni, S Kumar, V Krishna, S Sengupta Cancer Research 77 (13 Supplement), 4610-4610, 2017 | | 2017 |
| Abstract B52: 2-in-1 “sniper” nanomedicines rescue dendritic cells by two pronged inhibition of JAK2/STAT-3 and p38 MAPK pathways SK Natarajan, V Chandhrasekar, N Ismail, S Swaminathan, S Sengupta, ... Cancer Research 77 (2 Supplement), B52-B52, 2017 | | 2017 |
| Abstract LB-059: Supramolecular fusion nanotherapeutic mediated synergistic inhibition of PI3K and MEK pathways V Chandrasekar, SK Natarajan, S Sengupta, A Kulkarni Cancer Research 76 (14 Supplement), LB-059-LB-059, 2016 | | 2016 |
